Call | Senior Fellowship (SF) |
Programme | EDCTP2 |
Start Date | 2018-04-01 |
End Date | 2022-03-31 |
Project Code | TMA2016SF1511 |
Status | Active |
A randomized controlled trial of two versus three doses of Rotarix™ vaccine for boosting and longevity of vaccine immune responses in Zambia.
Objective 1. Assess boosting and longevity of antibody responses between infants receiving two versus three doses of Rotarix™ vaccine and evaluate safety of third dose. Objective 2: Profile innate and adaptive cellular, cytokines and secretory antibodies responses to Rotarix™ vaccination and investigate influence of cytomegalovirus exposure Objective 3: Determine genotypes and phenotypes of HBGA profiles and assess association with Rotarix™ vaccine immunogenicity Objective 4: Profile changes in rotavirus specific antibody titres and non-immunological components in maternal breastmilk over time and determine association with infant vaccine response
Institution | Country |
---|---|
Centre for Infectious Disease Research in Zambia (CIDRZ) | Zambia |
Name | Institution | Country |
---|---|---|
Roma Chilengi | Centre for Infectious Disease Research in Zambia | Zambia |
The proposed clinical trial is a phase IV or post licensure trial. It will have two arms and will be an open-label randomized controlled trial of two versus three doses of live, attenuated, oral Rotarix™ administered at 6 & 10 weeks (the standard of care arm) and at 6 & 10 weeks plus 9 months infants age (the experimental arm). The intervention in the experimental arm is an added third dose of Rotarix™ vaccine given at 9 months infant age
CIDRZ George Clinical Research Site, Lusaka Zambia |
Type | Name | Title | University | Start Date | End Date |
---|---|---|---|---|---|
PhD | Natasha Makabilo Laban | Miss | University of London - London School of Hygiene and Tropical Medicine | 2018 | 2022 |
MSc | Adriace Chauwa | Mr | University of Zambia | 2019 | 2021 |
Participants in follow up period. Primary outcome assessment in progress.
Centre for Infectious Disease Research in Zambia
Chief Scientific Officer
2018 | Development of a live attenuated rotavirus vaccine as a human infection challenge model MRC/UK-GCRF |
2018 | Characterisation of host immune responses to Salmonella Typhi in an endemic setting – A Comparison of Natural Typhoid Infection with Controlled Human Infection MRC/UK-GCRF |
2018 | Measurement of Shigella-specific antibodies in the first two years of life in Zambian children to refine correlates of protection and determine the optimal window for vaccination MRC/UK-GCRF |
2018 | An Open-label, Randomized, Controlled, Single Centre, Phase IIb Study to Assess the Immunogenicity, Reactogenicity and Safety of Three Live Oral Rotavirus Vaccines, ROTAVAC®, ROTAVAC 5CM and Rotarix® in Healthy Zambian Infants. PATH-USA |
2018 | A Phase 1 age descending placebo controlled clinical trial to examine the safety, tolerability, and immunogenicity of an oral inactivated ETEC Vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia. EDCTP |
2020 | ROTA-biotic-measuring the impact of rotavirus vaccines on paediatric antibiotic usage. Wellcome Trust |
2020 | Early clinical development of an oral Shigella vaccine through phase II study in Africa. EDCTP |
2020 | A Phase 3 double-blind, randomized, active comparator-controlled, group-sequential, multinational trial to assess the safety, immunogenicity, and efficacy of a trivalent P2-VP8 subunit rotavirus vaccine in prevention of severe rotavirus gastroenteritis in healthy infants MRC/UK |
2020 | Creating awareness for Human Infection Studies in Zambia. Wellcome Trust |
2019 | Phase 3 development of the first ETEC vaccine-ETVAX. EDCTP |
Type | Name | Title | University | Start Date | End Date |
---|---|---|---|---|---|
PhD | Natasha Makabilo Laban | Ms | University of London - London School of Hygiene and Tropical Medicine | 2018 | 2022 |
MSc | Adriace Chauwa | Mr | University of Zambia | 2019 | 2021 |
PhD | John Mwaba | Mr | University of Zambia | 2017 | 2020 |
PhD | Katayi Kazimbaya | Mrs | University of Zambia | 2016 | 2019 |
Role | Committee/board | Start Date | End Date |
---|---|---|---|
Chair | Data Safety Monitoring Board | 2017 | 2019 |
Chair | Data Safety Monitoring Board | 2018 | 2020 |
Member | Scientific Committee- Vaccines Against ETEC and Shigella | 2017 | 2022 |
Member | WHO Advisory Committee on Enteric Vaccines | 2016 | 2018 |
Institution | Degree | Year |
---|---|---|
University of London - London School of Hygiene and Tropical Medicine, United Kingdom | Master of Science | 2018-08-22 |
University of London - London School of Hygiene and Tropical Medicine, United Kingdom | Post Graduate Diploma | |
University of Zambia, Zambia | Bachelor of Medicine and Surgery | |
University of Zambia, Zambia | Bachelor of Science |
Diarrhoeal Diseases (DDs)